Tier 4 — mechanistic

Author Correction: Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

Zhao MM, Lu J, Li S, Wang H, Cao X, Li Q, Shi TT, Matsunaga K, Chen C, Huang H, Izumi T, Yang JK

Nature communications 2021 12(1):6342

Bibliography

PubMed: PMID 34716337
PubMed Central: PMC8556391
DOI: 10.1038/s41467-021-26635-8
Funding: Funding was not established from the accessible source; this is not a declaration of no funding.
Competing interests: A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.

Design	Published correction notice
Model	Published article correction
Sample	No new participants or experiments
Intervention	Correction of an author’s name in the KCNH6 paper
Duration	Correction published after the original article
Endpoints	Publication corrections or trial integrity; Interpretive implications

The notice corrects the spelling of an author’s name in the insulin-secretion paper.

The notice corrects the spelling of an author’s name in the insulin-secretion paper.

Supporting correction to PMID 34556670; no independent efficacy result.

Editorial review

Last verified 22 October 2026